Once Planned for Biomanufacturing Campus, Andover Facility Sells for $67M
Alexandria bought the huge facility in early 2022 as part of a $341 million, eight-property deal to take advantage of drugmaking demand that never materialized.
by James Sanna | Nov 26, 2024
Alexandria bought the huge facility in early 2022 as part of a $341 million, eight-property deal to take advantage of drugmaking demand that never materialized.
We're sorry, it appears you don't have the proper subscription to view this page. Please click the button below to purchase or renew your subscription and gain access to this content.
Questions? Please contact us at 617.896.5367, or send us an email at subscriptions@thewarrengroup.com.
It appears someone has logged in to your account from another device. Please click the button below to log back in on this device, and terminate all other sessions.
Questions? Please contact us at 617.896.5367, or send us an email at subscriptions@thewarrengroup.com.
Already have a subscription?
Need a subscription?
Special offer for new subscribers –
try B&T online for just $9.99 for your first month!
Just looking for the headlines?
If you need assistance with your subscription, please visit our customer service form or email customerservice@thewarrengroup.com.